SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $48,923,000 | +15.2% | 250,000 | 0.0% | 1.24% | +6.5% |
| Q2 2020 | $42,480,000 | +52.1% | 250,000 | +3.3% | 1.16% | +0.9% |
| Q1 2020 | $27,922,000 | +1.0% | 242,000 | 0.0% | 1.16% | +32.2% |
| Q4 2019 | $27,651,000 | +33.8% | 242,000 | 0.0% | 0.87% | +6.1% |
| Q3 2019 | $20,667,000 | +23.4% | 242,000 | 0.0% | 0.82% | +36.0% |
| Q2 2019 | $16,749,000 | -5.5% | 242,000 | 0.0% | 0.61% | -11.3% |
| Q1 2019 | $17,724,000 | +54.5% | 242,000 | +19.5% | 0.68% | +26.0% |
| Q4 2018 | $11,474,000 | +71.6% | 202,500 | +62.0% | 0.54% | +78.9% |
| Q4 2017 | $6,688,000 | -1.7% | 125,000 | 0.0% | 0.30% | -3.5% |
| Q3 2017 | $6,801,000 | +31.4% | 125,000 | +25.0% | 0.31% | +20.3% |
| Q2 2017 | $5,174,000 | – | 100,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |